FDA to evaluate Organs-on-Chips
The organs-on-chips are crystal clear, flexible polymers about the size of a computer memory stick that contain hollow channels fabricated using computer microchip manufacturing techniques. These channels are lined by living cells and tissues that mimic organ-level physiology.
Today the U.S. Food and Drug Administration (FDA) announced that it will be evaluating the organs-on-chips technology, originally developed at the Wyss Institute, towards identifying a more precise model for studying the effects of potential chemical and biological hazards found in foods, cosmetics or dietary supplements than is now available. The FDA will work with Emulate, Inc., a Wyss Institute startup, to evaluate the technology in laboratories at the agency's Center for Food Safety and Applied Nutrition.
Read more about the FDA's announcement here.
Learn more about the FDA's use of the liver-on-a-chip here.
Donald E. Ingber
Emulate Inc.
Kevin Kit Parker
Platelet
Inflammatory Diseases
Intestinal Disease
Mechanobiology
Disease Model
Organs on Chips
Translation News Wyss Institute's technology translation engine launches 'Organs-on-Chips' company
Press Release Wyss Institute Founding Director Donald Ingber elected to American Academy of Arts and Sciences
Press Release First entirely 3D-printed organ-on-a-chip with integrated sensors
Human Organs-on-Chips